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ABSTRACT 
               Seroprevalence study was conducted to investigate 
the presence of  antibodies against avian influenza virus  type 
A using ELISA test  in chickens in some farms in Khartoum 
North. Detection of antibodies against H5N1 and H7N1 out of  
the positive sera to  avian influenza virus  type A  using AGPT 
and HI test, respectively was also targeted.  
               Two hundreds and fifty serum samples were collected 
from apparently healthy chickens from different farms in 
Khartoum North in the period of January / February 2008. The 
serum samples consisted of 160 samples from layer chicken 
and 90 samples from broiler chicken. All sera samples were 
tested by ELISA to investigate the presence of antibodies 
against avian influenza virus type A. The results showed that 
19 serum samples out of 160 sera (11.9 %) from layer chicken 
were positive while 141 sera (88.9 %) were negative. In broiler 
chickens, 1 serum samples out of 90 sera (1.1 %) as positive 
while 89 sera (98.9 %) were negative. 
                AGPT was applied to the sera which were positive by 
ELISA to detect the antibodies against avian influenza type A, 
using H5N1 antigen. HI test was also applied to the same sera 
which were positive by ELISA to antibodies against avian 
influenza type A, using H7N1 antigen. The results of sera when 
tested against H5N1 antigen by AGPT showed that 0% of the 
 x
samples tested were positive, and when the same sera tested 
against H7N1 antigen by HI test the results also showed that 
0% of the samples tested were positive.  
                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 ﻤﻠﺨﺹ ﺍﻻﻁﺭﻭﺤﻪ
       ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﻠﺘﻘﺼﻲ ﻋﻥ ﻭﺠﻭﺩ ﺃﺠﺴﺎﻡ ﻤﻀﺎﺩﺓ ﻟﻔﻴﺭﻭﺱ ﺃﻨﻔﻠﻭﻨﺯﺍ ﺍﻟﻁﻴﻭﺭ 
, ﻓﻲ ﺍﻟﺩﺠﺎﺝ ﻓﻲ ﻋﺩﺓ ﻤﺯﺍﺭﻉ ﻓﻲ ﻤﻨﻁﻘﺔ ﺸﻤﺎل ﺍﻟﺨﺭﻁﻭﻡ ﺒﺎﺴﺘﻌﻤﺎل ﺍﺨﺘﺒﺎﺭ ﺍﻻﻟﻴﺯﺍ( ﺍﻟﻨﻭﻉ ﺃ)
ﻭﻜﺫﻟﻙ ﻟﻤﻌﺭﻓﻪ ﻭﺠﻭﺩ  ﺍﻷﺠﺴﺎﻡ ﺍﻟﻤﻀﺎﺩﺓ ﻟﻠﻔﻴﺭﻭﺱ ﺸﺩﻴﺩ ﺍﻟﻀﺭﺍﻭﺓ ﻭﺫﻟﻙ ﻤﻥ ﺨﻼل ﺍﻟﻌﻴﻨﺎﺕ 
   . ﺔ ﻻﺨﺘﺒﺎﺭ ﺍﻻﻟﻴﺯﺍﺍﻟﻤﻭﺠﺒ
  ﻤﻨﻁﻘﺔ ﺸﻤﺎل ﺍﻟﺨﺭﻁﻭﻡ ﻥ ﻋﻴﻨﺔ ﺩﻡ ﻤﻥ ﺩﺠﺎﺝ ﺼﺤﻲ ﻅﺎﻫﺭﻴﺎ ﻤ052       ﺘﻡ ﺠﻤﻊ ﻋﺩﺩ 
 061ﺘﺤﺘﻭﻯ ﺍﻟﻌﻴﻨﺎﺕ ﻋﻠﻰ . 8002ﻓﺒﺭﺍﻴﺭ ﻟﻠﺴﻨﻪ/51ﻴﻨﺎﻴﺭ ﻭﺤﺘﻰ /51ﻭﺫﻟﻙ ﻓﻲ ﺍﻟﻔﺘﺭﺓ ﻤﻥ 
ﺘﻡ ﺍﺨﺘﺒﺎﺭ ﺠﻤﻴﻊ ﺍﻟﻌﻴﻨﺎﺕ ﻋﻥ .  ﻋﻴﻨﻪ ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﻼﺤﻡ09ﻋﻴﻨﻪ ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺒﻴﺎﺽ ﻭ
 ﻋﻴﻨﻪ 061 ﻋﻴﻨﻪ ﻤﻥ 91ﻭﻜﺎﻨﺕ ﺍﻟﻨﺘﻴﺠﺔ ﻓﻲ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺒﻴﺎﺽ  , ﻻﻟﻴﺯﺍﻁﺭﻴﻕ ﺍﺨﺘﺒﺎﺭ ﺍ
  . ﻤﻭﺠﺒﻪ%( 1.1) ﻋﻴﻨﻪ 09 ﻋﻴﻨﻪ ﻤﻥ1ﻤﻭﺠﺒﻪ ﺒﻴﻨﻤﺎ ﻓﻲ ﺍﻟﺩﺠﺎﺝ ﺍﻟﻼﺤﻡ %( 9.11)
       ﺃﺴﺘﻌﻤل ﺍﺨﺘﺒﺎﺭ ﺍﻟﺘﺭﺴﻴﺏ ﻓﻲ ﺍﻻﺠﺎﺭ ﻋﻠﻰ ﺍﻟﻌﻴﻨﺎﺕ ﺍﻟﻤﻭﺠﺒﻪ ﻻﺨﺘﺒﺎﺭ ﺍﻻﻟﻴﺯﺍ ﺒﺎﺴﺘﻌﻤﺎل 
    1N5H .  ﻤﻭﺠﺒﻪ ﻟﻼﻨﺘﺠﻴﻥ%0ﻭﻜﺎﻨﺕ ﺍﻟﻨﺘﻴﺠﺔ , 
 ﺘﻡ ﺍﺴﺘﻌﻤﺎل ﺍﺨﺘﺒﺎﺭ ﺍﻟﺘﺭﺍﺹ ﻟﺨﻼﻴﺎ ﺍﻟﺩﻡ ﺍﻟﺤﻤﺭﺍﺀ ﻋﻠﻰ ﺍﻟﻌﻴﻨﺎﺕ ﺍﻟﻤﻭﺠﺒﻪ ﻻﺨﺘﺒﺎﺭ ﺍﻻﻟﻴﺯﺍ 
    ﺒﺎﻻﻨﺘﺠﻴﻥ 1N7H . ﻤﻭﺠﺒﻪ ﻟﻼﻨﺘﺠﻴﻥ%0ﻭﻜﺎﻨﺕ ﺍﻟﻨﺘﻴﺠﺔ , 
ﻟﻡ ﻴﺘﻡ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻰ ﺍﻟﻔﻴﺭﻭﺱ ﺸﺩﻴﺩ ﺍﻟﻀﺭﺍﻭﺓ ﻟﻼﻨﻔﻠﻭﻨﺯﺍ  ﻓﻰ ﺍﻟﻌﻴﻨﺎﺕ ﺍﻟﻤﺄﺨﻭﺫﺓ : ﺍﻟﺨﻼﺼﺔ 
  . 8002ﻓﺒﺭﺍﻴﺭ ﻟﻠﺴﻨﻪ/51ﻴﺭ ﻭﺤﺘﻰ ﻴﻨﺎ/51ﻤﻥ ﻤﻨﻁﻘﺔ ﺸﻤﺎل ﺍﻟﺨﺭﻁﻭﻡ ﻓﻰ ﺍﻟﻔﺘﺭﺓ ﻤﻥ 
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INTRODUCTION 
 
                 Avian influenza is a viral disease, caused by the influenza 
virus type A; which belongs to the family Orthomyxoviridae, can affect 
many species of domestic birds and wild birds. 
 
                 Type  A influenza viruses naturally occur in humans, horses, 
swine and birds (Ardans and Maclachlan, 2004). Avian influenza has 
become one of the biggest threats for human and animal health. For 
influenza A viruses, according to the envelope glycoprotein  there are 15 
different hemagglutinin (HA) antigens and 9 different neuraminidase 
(NA)antigens. There are many strains of Avian influenza viruses classified 
into: 1/ Highly Pathogenic Avian Influenza (HPAI) that can cause high 
mortality in birds, only subtypes H5 and H7 can caused HPAI,  2/ Low 
Pathogenic Avian Influenza (LPAI) that can cause little or no clinical signs 
in birds.  
                 Transmission between birds occurs  directly through secretions 
of infected birds such as faeces and respiratory secretions, or occurs  
indirectly through fomites  such as contaminated equipment, clothing and 
shoes of labour.  The clinical signs of the disease are sudden deaths  and 
high morbidity and mortality, oedema of the head and face and cyanotic 
combs and wattles, diarrhea, hemorrhages on legs  and declines in eggs 
production.  
                Stamping out, movement control, surveillance and vaccination 
have been implemented to control the disease. Vaccination is used in 
some countries, reducing susceptibility to infection and the amount of 
virus shed into the environment. It also helps avoid the depopulation of 
millions of animals(FAO, 2004a). 
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                Avian influenza was reported for the first time from Italy in 1878 
(Stubbs, 1965). Avian influenza was reported in the Sudan for the first 
time in 1925 (Annual Report of the Sudan Veterinary Service, 1925). 
According to the report of OIE (2006), highly pathogenic avian influenza 
subtype H5 has been reported for the first time in April 2006, an outbreak 
occurred  in Khartoum and Gezira states.  The total deaths of outbreaks 
were 63400 chickens, 27000 deaths in Khartoum North, 35000 in 
Khartoum state and 1400 in Gezira srate.   
 
                This study was conducted to investigate the presence of  
antibodies against avian influenza virus  type A in chickens in some farms 
in Khartoum North during 15 January to 15 February in 2008 using ELISA.  
The present of antibodies against H5N1 and H7N1 in the positive sera to  
avian influenza virus  type A using AGPT and HI test, respectively was 
also investigated.  
Objectives : 
1/ To detect antibodies against avian influenza virus type A using ELISA.  
2/ To detect antibodies against H5N1 and H7N1 in the positive sera to 
avian influenza virus type A using AGPT and HI test, respectively.  
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CHAPTER   ONE 
 
     REVIEW OF THE LITERATURE 
 
1.1 Definition of avian influenza  
 
                Avian influenza is a viral disease of fowls, which occurs as 
unapparent, mild, or acute and fatal.  The disease was first defined in 
1878 and  became known as fowl plague (Jordan, 1990). From the late 
1870s to 1981, highly pathogenic avian influenza (HPAI) was known by 
various names including fowl plague (most common), fowl pest,  peste 
aviaire, Geflugelpest, typhus exudatious gallinarium, Brunswick bird 
plague, Brunswick disease,  fowl  disease  and  fowl  or  bird  grippe  
(Stubbs, 1926; Stubbs, 1948). In 1981 the first international symposium 
on Avian Influenza, the terminology "highly pathogenic avian influenza" 
was adopted as the official designation for the highly virulent form of avian 
influenza (Allen  et al ., 1981).  
              Avian influenza is caused by  type  A  influenza  virus, in  the  
family    Orthomyxoviridae. Type A influenza  viruses  are  serologically  
categorized  into  15  hemagglutinin (H1-H15) and 9 neuraminidase    
(N1-N9) subtypes. All subtypes have been identified in birds. Infections by 
influenza virus have been reported in a variety of domestic and wild birds, 
but most infections are subclinical  (Swayne  et al ., 1998). 
                 Bird flu is primarily a disease of birds, but can cause human 
disease, the virus causes a respiratory infection with symptoms ranging 
from flu like symptoms (fever, cough, sore throat, muscle aches) to eye 
infections, pneumonia and acute and sever respiratory distress (Engelkirk 
and Wilson, 2006). The incubation period is usually three to seven days, 
depending upon the strain, the dose of inoculum, the species and the age 
of the bird( FAO, 2004a). The  outcome of infection produced  by AIV 
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isolation varies from no obvious clinical signs to 100% mortality (Swayne 
et al ., 1998).  
  
1.2  History of the disease 
 
                Avian influenza  was reported  for  the  first  time from Italy in 
1878 (Stubbs, 1965). The high mortality associated with influenza A  
H5N1infection (of both chickens and people) raised the specter of  a 
recurrence of a 1918 -1919 like pandemic which is estimated  to  have 
claimed in excess of 40 million lives world  wide  (Crosby, 1989). HPAI 
was reported in the United States in 1924-1925 and 1929. The 1929 
outbreak involved a few flocks in New Jersey (Stubbs, 1948). Quarantine, 
depopulation, cleaning and disinfection were used to eradicate HPAI from 
the United States (Swayne and Halvorson, 2003).  
                The outbreaks of HPAI between 1901 and the mid  1950s 
involved isolates that to day have been classified as H7N1 and H7N7 
subtypes (Easterday et al., 1997). However, an outbreaks during   1959 in 
chickens of Scotland and during 1961 in common terms (sterna hirundo) 
of South Africa involved new subtypes of AI viruses, H5N1 and H5N3, 
respectively (Swayne and Suarez, 2000). This led to the establishment of 
the erroneous dogma that all H5 and H7  AI viruses were highly 
pathogenic (Swayne and Halvorson, 2003). By the mid-twentieth century, 
HPAI had been diagnosed in most of Europe, North Africa, Middle East, 
Asia, South America and North America (Easterday and Tumova, 1972).    
               Recent epizootics in the  northeastern  United Kingdom  during 
1991, and Central Mexico in 1994-1995 were caused by H5 subtype 
viruses(Swayne  et al ., 1998). The ' bird flu ' (H5N1) outbreak in Hong 
Kong in 1997; which claimed the lives of six of its 18 victims, was 
terminated at the end of the year by the slaughter of the poultry in the live 
bird markets, which removed the source of infection (Claas et al., 1998; 
Subbarao et al., 1998; Bender et al., 1999). In 1997, the first documented 
case of avian influenza transmission to humans occurred in Hong Kong 
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(Hampton, 2004). In late 1998 in southern China and in early 1999 in 
Hong Kong, cases of mild influenza caused by another influenza A 
subtype, H9N2, indicated the repopulated bird markets still harboured 
potential human pathogens (Peiris et al., 1999; Lin et al ., 2000). 
                Beginning in January 2004, the World Health Organization 
(WHO) confirmed reports of new outbreaks of HPAI  H5N1  infection  
among  poultry  and  waterfowl in several Asian countries.    In 2005, 
outbreaks of H5N1 disease have also been reported among poultry in 
Russia, Ukraine, Kazakhstan, Turkey and Romania. Mangolia has 
reported outbreaks of the H5N1 in wild, migratory birds (Agwunobi, 2006).      
 
1.3  Transmission  of the causative  virus 
  
                The virus is transmitted by direct contact between infected and 
susceptible birds or indirect contact through aerosol droplets or exposure 
to virus-contaminated fomites (Easterday et al., 1997). Waterfowl have 
been implicated as the major natural reservoir for influenza. Infected 
ducks can shed virus for prolonged periods without showing clinical signs 
or producing a detectable antibody response  (Ardans and Maclachlan, 
2004). 
                The avian influenza A virus H5N1 was transmitted to humans 
primarily by contact with live birds and not by contact with meat or animal 
products (Krauss et al., 2003).  
                AI virus is excreted from the nares, mouth, conjunctiva and 
cloaca of infected birds into the environment because of virus replication 
in the respiratory, intestinal, renal and/or reproductive organs (Swayne 
and Halvorson, 2003). The disease is transmitted through poultry flocks 
mainly through ingestion of virus, but it may also be transmitted by 
inhalation and by mechanical means involving movement of personnel 
throughout flocks or between premises. Furthermore, some believe that 
for waterfowl, a fecal-water-cloacal route of transmission may be 
important in addition to the fecal-water-oral route. Outbreaks of highly 
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virulent avian influenza may be self limiting  because few birds survive the 
disease to serve as carriers (Ardans and Maclachlan, 2004). 
                Vertical transmission occurs when infected embryos survived 
and hatched, this was supported by the isolation of the virus from the 
albumen and yolk of eggs laid by hens at the height of the disease 
(Beard,1992). 
1.4. Epizootiology  
 
                Avian influenza viruses are endemic in wild bird and migratory 
waterfowl populations and can be transmitted to domestic poultry. Some 
influenza subtypes are also capable of infecting mammalian species, in 
particular swine and humans (WHO, 2004). Influenza viruses exhibit 
varying degrees of adaptation to individual host species with frequent and 
easy intraspecies transmission (Swayne, 2000). All subtypes (defined by 
the combination of H and N antigens) are perpetuated in wild aquatic bird 
populations, including ducks, shorebirds and gulls, which act as a natural 
reservoir for influenza A viruses (Webster et al., 1978).   
                 The susceptibility of pigs to infection by both avian and human 
viruses led to the notion that pigs may have a role as an intermediate 
host, not only in transmission of avian viruses to the human population, 
but also as a 'mixing vessel' to promote genetic reasortment between 
avian and human virus genomes to facilitate the emergence of a potential 
pandemic strain (Scholtissek et al., 1985). Human influenza A viruses fail 
to infect the intestinal tract of birds after oral inoculation, and studies with 
avian-human influenza A reassortant viruses suggest that both the HA 
and NA of avian viruses are critical in allowing transmit through the 
digestive tract and replication in intestinal epithelial cells of ducks 
(Hinshaw et al., 1982,  1983).  
      
1.5  Clinical  disease 
               The Clinical signs are very variable and are influenced by 
factors such as the virulence of the infecting virus, species affected, age, 
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sex, concurrent diseases and environment (FAO, 2004a). Although no 
clinical disease signs are characteristic of all isolates in all species,  
common signs in poultry include slight-to-severe declines in eggs 
production; increased mortality; diarrhea; respiratory  difficulties; edema of 
the head, comb and wattles (Swayne et al., 1998). A few strains produce 
systemic infection accompanied by central nervous system (CNS) 
involvement, with death occurring within 1 week (Wright and Webster, 
2001). Sick birds often sit or stand in a semi-comatose state with their 
heads touching the ground (FAO,2004a). Viruses of the H5 and H7 
subtypes can cause highly pathogenic avian influenza, a systemic 
disease of high morbidity and mortality in domestic poultry (Suarez, 
2000). Most outbreaks produce respiratory signs such as sneezing, 
coughing, sinusitis and lacrimation, other signs include depression, 
diarrhea and decline in egg production or fertility   (Ardans and 
Maclachlan, 2004). 
 
1.6. Lesions  
 
                   Lesions of the disease in chickens vary according to the strain 
of the infecting virus (Easterday and Beard, 1984). During post mortem 
examination,  fluid and mucous exudates from the nares,  oral cavity, the 
trachea and subcutaneous edema of the head and neck may be 
observed. The conjunctivae are severely congested, often presenting 
petechia. Pinpoint petechiae are frequently observed on the inside of the 
keel, the abdominal fat (Swayne and Halvorson, 2003). Severe disease 
can be accompanied by the presence of hemorrhage on the serosal and 
mucosal  surfaces of viscera including the proventriculus, on the shanks 
of the legs, and on the comb and wattles. Ruptured mature ovarian 
follicles (yolks) and accompanying inflammation ('peritonitis') are 
frequently observed in active layers. Birds that die peracutely may exhibit 
few,  if any,  obvious clinical signs or gross lesions (Swayne et al., 1998). 
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                   Microscopic lesions in domestic poultry include edema, 
hyperemia, hemorrhage, or focal necrosis in lymphoid tissues, pancreas, 
heart, skeletal muscle, brain and kidney (Easterday and Tumova, 1972). 
 
1.7. Pathogenicity  
                  In addition to the immune status of the population and its 
susceptibility to infection, the impact of influenza depends on the 
pathogenic potential of the virus, exacerbation by secondary infections, as 
well as environmental factors (Hay, 2001).  
                  Virus infectivity is dependent on proteolytic cleavage of the 
hemagglutinin precursor HAO to HA1 and HA2 to generate the N-terminal 
'fusion peptide of HA2' which is directly involved in promoting membrane 
fusion between the virus and endosome membranes during virus  
infection  (Maeda and Ohnishi, 1980; Skehel et al., 1982).                                     
                  Susceptibility of the HA to cleavage activation by intracellular 
proteases is a prime determinant of the high pathogenicity of ' Fowl 
Plague ' viruses of H5 and H7 subtypes, which cause systemic infection 
and rapid death in domestic poultry, including chickens and turkeys. The 
broad tissue tropism of these viruses, in contrast to the more localized 
respiratory or cloacal infection by low pathogenicity strains, is primarily 
due to the presence of a sequence of basic amino acids at the proteolytic 
cleavage site (Stieneke – Grober et al., 1992;  Horimoto et al., 1994). 
Multiple replication cycles occur in respiratory and /or intestinal tracts with 
release of infectious virions.  In poultry, the nasal cavity is major side of 
initial replication. With Highly Pathogenic Avian Influenza, the virions 
invade the submucosa,  entering capillaries. The virus replicates within 
endothelial cells and spreads via the vascular or lymphatic systems to 
infect and replicate in a variety of cell types in visceral organs,  brain  and 
skin. The presence of a hemagglutinin proteolytic cleavage site that can 
be cut by ubiquitous furin-like cellular enzymes is responsible for this 
pantropic replication. Damage caused by AI viruses is the result of one of 
three processes: 1/ direct virus replication in cells, tissues and organs; 2/ 
 9
indirect effects from production of cellular mediators such as cytokines; 
and 3/ ischemia from vascular thrombosis (Swayne and Halvorson, 2003). 
Proteases produced by co-infecting bacteria or mycoplasmas  may also 
participate and have been shown to be responsible for promoting virus 
replication in the lower respiratory tract and exacerbating the severity of 
disease (Tashiro et  al., 1987;  Webster and Rott, 1987).  
 
1.8. Characteristics of influenza virus  
 
                      Influenza viruses are members of the virus family 
Orthomyxoviridae. They are pleomorphic, enveloped viruses,  
approximately 80-120 nm in diameter (Olsen et al., 2006), is spherical or 
elongated with numerous hollow and cylindrical spheres about 9nm long 
and 1.5 to 2 nm wide (Hagan et al., 1988),  with a segmented genome of 
eight negative-sense stranded RNA segments (Murphy and Webster, 
1990).  
                    Influenza virus particles are irregularly shaped. The virion 
envelope is derived from the membranes of host cells.  There are two 
distinct types of surface spikes (peplomers); one is rod-shaped and 
corresponds to the hemagglutinin (HA), and the other is mushroom-
shaped and possesses neuraminidase (NA) activity. Both the HA and the 
NA are viral glycoprotein that attach to the viral envelope by short 
sequences of hydrophobic amino acids. The viral envelope surrounds a 
matrix protein (M) shell, which in turn surrounds the genome, along with 
the nucleoprotein (NP)  and three large proteins (PBI, PB2 and PA) that 
are responsible for RNA replication and transcription (Ardans and 
Maclachlan, 2004). 
                     The three largest RNA segments of influenza A virus encode 
the proteins of the influenza polymerase complex, denoted PB1, PB2 and 
PA on the basis of their mobility in two-dimensional electrophoresis 
(Kingsbury, 1990). RNA segment four encodes the hemagglutinin (HA) of 
influenza A virus (Wiley and Skehel, 1987). RNA segment 5 (or 6, 
depending on the gel system used) encodes the viral neuraminidase (NA) 
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(Colman and Ward, 1985). RNA segment 6 (or 5, depending on the gel 
system used) encodes the nucleoprotein (NP). The NP interacts with RNA  
as a structural  component of the virion and also associates with the three  
polymerase  proteins  to  form  the  transcriptase  complex. The  seventh 
RNA segment of influenza A virus encodes the two matrix proteins, M1 
and M2. RNA segment 8 encodes the two nonstructural proteins NS1 and  
NS2 (Lamb, 1989).  
 
1.9.  Classification of  avian  influenza virus  
  
                     Hagan et al.,  (1988) reported that the virus is classified into:  
 
Family :            Orthomyxoviridae  
Genus :             Orthomyxovirus  
Type species :   Type  A  
Subtypes:                 (1) Human  influenza viruses  
                                         A /PR8/34 
                                    A1/Cam/46  
                                    A2/Singsore /1/57  
                              (2)  Equine influenza viruses  
                                    Equi-1/Praha/56 
                                    Equi-2/Miami/63 
                               (3)  Porcine  influenza viruses  
                                      A/SW/Lowa/31  
                                      A/SW/Wis/ 61  
                                      A/SW/Wis/68 
                                (4)   Avian influenza viruses  
                                       Fowl Plague/27 
                                       A/Duck/Czech/56 
                                       A/Duck/Eng/56 
                                       A/Chick/Scot/59 
                                       A/Turkey/Can/63 
                                       A/ Turkey/Ontario/7732/66 
                                       A/Quail/Italy/1117/65  
Type species :    Type  B  
Subtypes :                   Human  influenza viruses  
                                     B/Lee/40  
                                     B/Johannesburg/59  
                                     B/Taiwan/62 
Type species :   Type  C 
Subtypes :                   Human  influenza virus  
C/Taylor/1233/47                                                 
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based on differences between their nucleoprotein and matrix protein 
antigens(FAO, 2004a).  
                   Murphy et al., (1999) and  Quinn  et al., (2002)  mentioned 
that the family Orthomyxoviridae  comprises the genera  Influenza virus 
A, Influenza virus  B, Influenza virus  C and Thogotovirus. 
 
1.10. Properties of Avian Influenza Viruses  
1.10.1. Physical Properties  
 
                  The virus is stable at -70°C  and remains in the lyophilized 
state for years (Hagan and Bruner, 1988). Thermostability is variable 
among the strains; some survive for 6 hours at 56°C (Swayne et al., 1998) 
but was destroyed after 5 minutes or less at 60 °C (Moses et al., 1948). 
The optimum temperature for virus synthesis is 37°C (Robert et al., 1978). 
Infectivity persisted for 4 days at 22°C and 30 days at 0°C in natural water 
(Webster et al., 1978). Influenza viruses are inactivated by ultra-violet, 
irradiation. They are relatively stable at PH 7-8 but labile at low PH (Lang 
et al., 1968). The lipid envelope makes the viruses highly susceptible to 
detergents and most commonly used antiviral disinfectants (Olsen et al., 
2006).  
 
1.10.2. Chemical Properties 
                  Influenza viruses encode up to 11 viral proteins on 7 to 8 
separate segments of negative- sense RNA (Olsen et al., 2006). The 
approximate composition of the influenza virions is reported as 0.8-1.1% 
RNA, 70-75% proteins, 20-24 % lipid and 5-8 % carbohydrate. The lipids 
are located in the viral membrane; most of them are phospholipids with 
smaller amounts of cholesterol and glycolipids (Choppin and Compans, 
1975). Carbohydrates are located in the viral envelope in two layers, in 
the spikes linked to protein and in the lipid layer linked to lipid. The 
carbohydrates include ribose,  galactose,  mannose, fructose and glucose 
(Easterday and Beard, 1984).    
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1.10.3. Biological Properties 
                 All strains of influenza are capable of agglutinating erythrocytes 
from humans, guinea pigs and chickens as well as many other species 
(Ardans and Maclachlan, 2004). The pathogenicity of viruses (of which 
there are 15 known subtypes identified as H1-H15) can be classified as 
low to high, dependent on the severity of disease caused. Of the 15 avian 
influenza virus subtypes, H5N1 is of particular concern because it mutates 
rapidly and has a documented propensity to acquire genes from viruses 
infecting other animal species (WHO, 2004). The ability of the HA to be 
cleaved by cellular proteases has been correlated with virulence of avian 
influenza viruses in birds (Webster and Rott, 1987).  The NA has been 
found to play a secondary role in virulence (Ogawa and Ueda, 1981). 
 
1.10.4. Replication of avian influenza virus  
 
                  A  major function of the influenza HA in virus replication is 
attachment to cell surface sialyloligosaccharides which serve as virus 
receptors. The receptor specificities of human and avian HAs differ, 
suggesting that the distribution of receptors in mammals and birds may be 
a determinant of host range (Rogers and Paulson, 1983). A second  
important function of the HA is fusion of the viral membrane with the cell 
membrane and subsequent entry of the virus into the cell (Wiley and 
Skehel, 1987). The separate RNPs with their negative-sense genome  
segments are transported to the nucleus where viral mRNA synthesis 
begins. Viral mRNA synthesis require the activity of at least two influenza 
virus polymerase subunits; PB1 and PB2. PB1 has active sites that bind 
the conserved 3' and 5' sequences of vRNA, as well as the endonucleus 
activity necessary to cleave the host cap sequence. In addition, PB1 has 
the polymerizing activity of the complex. PB2 has cap binding activity and 
it is to this subunit that the host pre-mRNA binds. Cleaving of the small " 1 
to 13 nucleotide " cap structure from the host begins the process of 
mRNA synthesis, during which a capped, subgenomic  copy of the vRNA 
is produced. Synthesis stops about 15 to 22 nucleotides short of the 5' 
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end of the vRNA, where a small '4 to 7 nucleotide'  U region serves to 
causes stuttering or reiterative synthesis, producing a poly 'A' tail. Viral 
RNA  synthesis must switch from making mRNA to making full length 
template RNA and then new vRNAs. This switch requires the presence of 
multiple copies of the viral protein NP, as well as the polymerase subunit 
PA. Since all viral RNA synthesis takes place in the nucleus, it is 
necessary that newly replicated genomes be transported to the cytoplasm 
for maturation of new virus particles. This transport takes place when new 
vRNA molecules complex with two viral proteins: M1 and NS2. Flu 
nucleocapsids that have been assembled in the nucleus and transported 
into the cytoplasm migrate to the cell surface where virions bud off 
(Wagner and Hewlett, 2004). 
                      
1.10.5. Genetic change of avian influenza virus         
                     Influenza A viruses exhibit greater genetic and antigenic 
diversity and comprise a variety of antigenically distinct subtypes, 
including various combinations of 15 HA (H) and 9 NA (N) subtypes 
(Webster et al., 1992). The diversity of influenza A viruses is further 
enhanced by the high frequency of genetic reassortment (recombination) 
between the segmented genomes of two viruses following dual infection 
of a cell (Webster et al., 1978).  
                     The influenza A genome contains at least 10 different open 
reading frames (genes) in its 8 segments of negative-sense RNA. The 
segmented genome of influenza viruses facilitates reassortment, resulting 
in the production of new strains. Influenza viral variation is frequent and 
occurs in two ways, drift and shift. Antigenic drift is due to point mutations 
resulting in amino acid substitutions mainly in the HA protein. Antigenic 
shift occurs with reassortment of individuals RNA segments when a cell is 
infected with two different influenza viruses, generating new viruses that 
cause pandemics of human influenza (Ardans and Maclachlan, 2004).  
 
  
1.11. Diagnosis  
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1.11.1 Clinical Signs  
                  
                 The presence of avian influenza clinical signs and lesions may 
a route considerable suspicion(Jungheer et al., 1946). 
 
1.11.2. Direct Detection of AI Viral Proteins or Nucleic 
Acids  
                 Skeeles et al., 1984 described the use of fluorescent antibody 
test for the rapid detection of avian influenza virus in tissue samples 
during the Pennsylvania disease outbreak, and Kodihalli et al., 1993  
described an antigen-capture ELISA to detect viral antigens in samples. 
 
1.11.3. Isolation of Avian Influenza Virus  
              Avian influenza viruses are commonly recovered from tracheal 
and cloacal swabs of either live or dead birds, because most HP and MP 
AI viruses replicate in the respiratory and intestinal tracts. The swabs 
should be placed in a sterile transport medium containing high levels of 
antibiotics to reduce bacterial growth(Swayne et al., 1998). Tissues, 
secretions, or excretions from these tracts are appropriate for virus 
isolation .  Before testing for virus, tissues should be ground as a 5-10% 
suspension in the transport medium and clarified by low-speed 
centrifugation. Chicken embryos, 10-11days old, are inoculated via the 
allantoic cavity with approximately 0.2ml of sample. After 72hours, or at 
death, the eggs should be removed from the incubator, chilled, and 
allantoic fluids should be collected. The presence of virus is demonstrated 
by chicken erythrocyte  hemagglutinating activity in the allantoic fluid 
(Swayne and Halvorson, 2003).  
                 Some avian strains grow in chicken and monkey kidney cell 
cultures (Pereira et al., 1965). Trypsin has to be added to cell culture 
medium to allow the proteolytic cleavage of HA (Krauss et al., 2003).     
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1.11.4. Serology   
1.11.4.1. Agar Gel Precipitation Test  
                 AGPT have been widely and routinely used to detect specific 
antibodies in chicken and turkey flocks as an indication of infection. These 
have generally employed nucleocapsid-enriched preparations made from 
the chorioallantoic membranes of embryonated fowl eggs (Beard, 1970)  
that have been infected at 10 days of age, homogenised, freeze–thawed 
three times, and centrifuged at 1000g. The supernatant fluids are 
inactivated by the addition of 0.1% formalin or 1% betapropiolactone,  
recentrifuged and used as antigen (OIE,  2005). 
 
1.11.4.2. Hemagglutination (HA) and Hemagglutination  
Inhibition (HI) tests 
                Variations in the procedures for HA and HI tests are practised in 
different laboratories. The following recommended examples apply in the 
use of U-bottomed microwell plastic plates in which the final volume for 
both types of test is 0.075 ml (OIE, 2005). 
 
1.11.4.2.1. Hemagglutination (HA) test 
                HA is determined by tilting the plate and observing the presence 
or absence of tear-shaped streaming of the RBCs. The titration should be 
read to the highest dilution giving complete HA (no streaming); this 
represents 1 HA unit (HAU) and can be calculated accurately from the 
initial range of dilutions (OIE, 2005).  
 
1.11.4.2.2. Hemagglutination  Inhibition (HI) test 
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                    The HI test allows avian influenza H subtypes to be 
differentiated  on the basis of the antigenic character of the H.  HI  testing 
for subtyping purposes is best suited for references laboratories, 
especially because sera may need to be treated with a receptor-
destroying enzyme to eliminate nonspecific HI reactions (Palmer et al., 
1975). The HI titer is reciprocal of the last dilution of antiserum that 
completely inhibits hemagglutination  (WHO,  2002).  
 
1.11.4.3. Neuraminidase  Inhibition (NI) test 
                      The NI test allows AIV to be differentiated on the basis of 
the antigenic character of the N (Swayne et al., 1998). The result is a 
visible colour change that can be observed by eye (FAO, 2004b).   
 
 1.11.4.4. Enzyme-linked immunosorbent assays (ELISA)  
                     An indirect ELISA test kit to detect type A group-specific 
RNP and M antibodies is available (Adair et al., 1989). The indirect ELISA 
is a reliable test amenable to semiautomation and the rapid survey of 
large numbers of samples,  but test results should be interpreted on a 
flock and not an individual bird basis (Swayne et al., 1998). 
 
1.11.5. Molecular Techniques 
Reverse transcriptase –polymerase chain reaction(RT-
PCR) 
                 Reverse transcriptase- polymerase chain reaction (RT-PCR) 
procedures have been developed to detect the presence of nucleic acid of 
influenza virus in clinical samples and to identify virulence markers 
associated with HPAI viruses in subtypes H5 and H7 (Horimoto and 
Kawaoka, 1995). Tracheal samples from infected birds showed high 
sensitivity and specificity relative to virus isolation, RT-PCR tests on 
faecal samples lacked sensitivity  (OIE, 2005). 
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1.12. Vaccination 
 
                   Inactivated influenza virus vaccines have been used in a 
variety of avian species, and their effectiveness in preventing clinical 
signs and mortality is well documented.  However,  protection is virus 
subtype specific. Birds are susceptible to infection with influenza viruses 
belonging to any of the 15 HA subtypes, and there is no way to predict 
their exposure to any particular one.  It is not practical to use preventive 
vaccination against all possible subtypes. After an outbreak occurs and 
the subtype of the virus is identified,  however, vaccination may be a 
useful tool (Halvorson et al., 1987). 
                   Conventionally, vaccines that have been used against NAI or 
LPAI have been prepared from infective allantoic fluid inactivated by beta-
propiolactone or formalin and emulsified with mineral oil. Recombinant 
vaccines for AI viruses have been produced by inserting the gene coding 
for the influenza virus haemagglutinin into a live virus vector and using 
this recombinant virus to immunise poultry against AI (OIE, 2005).   The 
recombinant fowlpox-AI-H5 vaccine is licensed in El Salvador, 
Guatemala,  Mexico and the USA (Swayne, 2003). Recently, a large 
randomized trail looked at an H5N1 attenuated vaccine from the Vietnam 
strain. Only a modest immunologic response was seen, with 
microneutralization antibodies being developed at 12 times the dose for 
seasonal influenza. The side effects were minimal (Sandrock, 2007).  
                
1.13. Treatment  
                       Two drugs (in the neuraminidase inhibitors class), 
oseltamivir (commercially known as Tamiflu) and zanamivir (commercially 
known as Relenza) can reduce the severity and duration of illness caused 
 18
by seasonal influenza. The efficacy of the neuraminidase inhibitors 
depends, among others, on their early administration (within 48 hours 
after symptom onset). The H5N1 virus is expected to be susceptible to the 
neuraminidase inhibitors. Antiviral resistance to neuraminidase inhibitors 
has been clinically negligible so far but is likely to be detected during 
widespread use during a pandemic. 
                     An older class of antiviral drugs, the M2 inhibitors 
amantadine and rimantadine, could potentially be used against pandemic 
influenza, but resistance to these drugs can develop rapidly and this could 
significantly limit their effectiveness against pandemic influenza. 
                    For the neuraminidase inhibitors, the main constraints-which 
are substantial–involve limited production capacity and a price that is 
prohibitively high for many countries.  
                    So far, most fatal pneumonia seen in cases of H5N1 infection 
has resulted from the effects of the virus, and cannot be treated with 
antibiotics. Nonetheless, since influenza is often complicated by 
secondary bacterial infection of the lungs, antibiotics could be life-saving 
in the case of late-onset pneumonia (WHO,  2005). 
 
1.14. Control   
  
                  Strategies to control avian influenza virus are developed to 
prevent, manage or eradicate the virus from a country, region, state  or 
farm. These strategies are developed using various aspects of five 
component: 1/ biosecurity (including quarantine ), 2/ diagnosis and 
surveillance, 3/ eliminating poultry infected with AI virus, 4/ decreasing 
host susceptibility to the virus and 5/ education of all personnel on 
infectious diseases and their control (Swayne and Suarez, 2005).  
                 Without the application of monitoring systems, strict biosecurity 
and depopulation in the face of infection, there is the possibility that these 
viruses could become endemic in vaccinated poultry populations (OIE, 
2005). At the international level, countries must be willing to report 
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disease outbreaks; the disease is thereby notifiable and restrictions apply 
to the movement of birds or avian products (Murphy et al., 1999). 
1.15. Avian Influenza virus infections in Sudan 
 
                 The disease was reported in Sudan for the first time in 1925 
(Annual Reports of Sudan Veterinary Service).  
                  Elmubark (1970) was unable to isolate the virus when he 
carried out a survey on respiratory disease in fowl.  
                  Elamin and Kheir (1985) conducted a serological survey using 
the AGPT to detect antibodies to influenza virus in large animal sera in 
Kassala region. Their results showed that positive reaction for influenza 
virus type A were obtained in 2 (4.7 %) of camel sera, 4 (5.4 %) of goat 
sera, 6 (7.2 %) of sheep sera, 2 (2.9 %) of cattle sera and no antibodies 
were detected in donkey sera.  
                 Elamin (2000) was confirmed for the first time the presence of  
avian influenza in the Sudan. Her results showed 13 isolates agglutinated 
chicken RBCs  from 97 samples (33 tracheal swabs, 22 cloacal swabs 
and 42 tissues; lung, trachea, liver, spleen  and  heart).    6.5 % of the 
isolates which  agglutinated chicken RBCs  were inhibited using influenza 
antiserum  (H3N2)  using HI test. 
                 Eltahir (2006) carried out a study to standardize the agar gel 
precipitation test for detection of avian influenza in  200 sera collected 
from human and chicken. Her results showed that the most AGPT 
standard method that can be used for diagnosis of AI  by using purified 
agar in normal saline with addition of sodium deoxycholate. The result 
revealed that  24 out of 100 human sera and 32 out of 100 chicken sera 
were positive to antibodies against  AI  A virus, when using the standard 
AGPT procedure. 
                 Saeed (2006) was conducted a study to standardize 
hemagglutination and hemagglutination inhibition tests for avian influenza 
viruses and applicated the standard method for detection of antibodies in 
100 sera collected randomly from chicken and 100 sera from human by 
using HI test against H7 and H5 antigens. The results showed that 21 out 
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of 100 sera  colleced from chicken were positive to H7 antigen. In the 
same sera 2 out of 100 sera were positive to H5 antigen. Also,  the results 
showed that 15 out of 100 sera  collected from human were positive to H7 
antigen. In the same sera 1  out of 100 sera were positive to H5 antigen.   
                According to the report of OIE (2006),  highly pathogenic avian 
influenza subtype H5  has been reported for the first time in 19/4/2006, an 
outbreak occurred  in Khartoum and Gezira states. The disease was 
diagnosed  in Central Veterinary Research Laboratory and  the result was 
positive for H5. The total deaths of outbreaks were 63400 chickens, 
27000 deaths in Khartoum North, 35000 in Khartoum state and 1400 in 
Gezira srate.  
                 Ali and Kheir (2007) isolated a highly  pathogenic avian 
influenza     H5N1  from the outbreak in April 2006. They isolated the virus 
from samples consisted of organs (trachea,  lung, intestine and spleen) 
and tracheal and clocal swabs. The samples collected from 6 farms in 
Khartoum and 2 farms Gezira. The samples were tested by rapid 
immunochromatographic  assay and then subtyped to isolation in 
embryonated eggs.      
                 Kamaleldein (2007) was conducted a study to detect Abs 
against  avian influenza virus type A  by using agar gel precipitation test. 
She collected 200 sera from chicken and human. The result showed that 
56.3% out of 190 chicken sera and 70% out of 10 human sera were 
positive  to  antibodies against  AI  A virus type A. She subtyping the 
positive sera by using antigens of H5N1 and H7N3 by HI test. She found 
32.1 % and 1.8 % out of 56 sera were positive to H7N3 and H5N1 
antigen, respectively in layer chicken. 5.9 % out of 51 sera were positive 
to H7N3 antigen in broiler chicken  and  when the same sera  tested 
against H5N1 gave negative result.  The result of sera collected from 
human, 4 sera out of 7(57.1%)  were positive  to H7N3 antigen using HI 
test. The sera when tested against H5N1 gave negative result.  
                   Ali et al., (2007), they reported that 911 serum samples out of 
1054(86.4 %)  were positive when tested by indirect ELISA to detect 
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antibodies against avian influenza type A. The samples were collected 
from unvaccinated  chickens in different localities in Sudan during 2003 to 
early 2006.  
 
CHAPTER   TWO 
 
  MATERIALS  AND   METHODS 
 
 
 
2.1. Study area 
                 Two hundreds and fifty blood samples were collected from 
apparently healthy chickens from different farms in Khartoum North    
during 15 January to 15 February in 2008 (Table 1).  
               The blood samples consisted of 160 samples from layer  and 90 
samples from broiler (Table 2). 
 
Table 1 :  
Location, type of chicken, breed, age, number of chicken in farm and 
number of serum samples 
  
 
Number of 
serum 
samples 
Number 
of 
chicken 
in farm
Age of 
chicken 
Breed of 
chicken 
Type of 
chicken 
Location  
7 (0.8%)
9 (0.45%)
9 (0.9%)
32 (0.64%)
21 (0.7%)
33 (0.41%)
15 (0.5%)
48 (0.4%)
13 (0.4%)
10 (0.7%)
18 (0.45%)
19 (0.4%)
16 (0.64%)
900
2000
1000 
5000 
3000 
8000 
3000 
12000 
3500 
1500 
4000 
5000
2500
40weeks
5 weeks
32 weeks
72 weeks
8 weeks
4 weeks
80 weeks
6 weeks
48 weeks
16 weeks
56 weeks
60 weeks
24 weeks
Lohman
Habard 
Hyline
Lohman
Hyline
Habard
Hisex
Habard
Lohman
Hisex
Hisex
Hisex
Hyline
Layer 
Broiler
Layer 
Layer 
Layer 
Broiler 
Layer 
Broiler 
Layer 
Layer 
Layer 
Layer 
Layer
Shambat 1
Halfaia 1 
Shambat 2 
Droshab 1 
Droshab 2
Droshab 3
Elkabashi 1
East Nile
Kadro 1
Kadro 2
Kadro 3
Elkabashi 2
Halfaia 2
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Table 2: 
  Distribution of collected sera by chicken type   
 
Number of samples Type of chicken
160
90
250 
Layer
Broiler
Total
 
 
 
2.2. Collection of blood  samples 
 
                Blood was collected from the wing vein of chicken using 1ml 
disposable  syringes and left in a sloping position at room temperature,  
over night to clot. Serum was then separated from the clot, centrifuged at 
1000 rpm for 5 minutes  with a  micro-centrifuge. Separated sera  were  
kept  in labeled Eppendorf  tubes and stored at -20 C until used.  
                
2.3.    ELISA (Enzyme Linked Immuno-sorbent  Assay)      
 
                    The AI   ELISA  kit was  obtained  from Biochek  Company in  
Holland. This kit was used to measure the amount of antibody to AI in the 
serum of  chickens.  
 
2.3.1. Materials and Reagents provided with the kit  
  
1/ AI coated  plates.  Inactivated viral antigen on microtitre plates.  
2/ Conjugate Reagent: sheep anti-Chicken Alkaline phosphatase in Tris 
buffer with protein stabilizers, inert red dye and sodium azide preservative 
(0.1%W/V).  
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3/ Substrate Tablets: PNPP(P-Nitrophenyl Phosphate) tablets to dissolve 
with substrate buffer.  
4/ Substrate Buffer: diethanolamine buffer with enzyme co-factors.  
5/ Stop Solution: sodium  hydroxide in diethanolamine buffer.  
6/ Sample  Diluent: phosphate buffer with protein stabilizers and sodium 
azide preservative (0.1 % W/V).  
7/ Wash Buffer: powdered phosphate buffered saline with tween . 
8/ Negative Control: specific pathogen free serum in phosphate buffer 
with protein stabilizers and sodium azide preservative (0.1%W/V).  
9/ Positive Control: antibodies specific to AI in phosphate buffer with 
protein stabilizers and sodium azide preservative (0.1%W/V). 
 
2.3.2. Equipment and Reagents required in the test 
1/  Precision pipettors  and disposable tips 8 or 12  channel  pipette / 
repeater pipette.  
2/  Plastic tubes for sample dilution.  
3/  Distilled or deionised water.  
4/  Microtitre plate reader with 405 nm filter.  
5/  Microtitre  plate washer.  
 
2.3.3. Sample  Preparation 
                Each serum sample was diluted 1:500  by adding 0.001ml to  
0.5ml of sample diluent in a plastic tube. Each separate sample was took  
by a fresh pipette tip and the receiving tube clearly identified with sample 
number. Then tubes were  mixed well or  shook  the  tubes for 1 minute . 
                Positive and negative kit controls do not require dilution.  
 
2.3.4. Reagent Preparation 
 
               All reagents were allowed to come to room temperature before 
used. 
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1/  Substrate Reagent: 1tablet were added to 5.5 ml of substrate buffer 
and mixed until fully dissolved, the prepared reagent were made on day of 
use.  
2/ Wash Buffer: contents of one wash buffer sachet were empted into one 
liter of distilled water and mixed until fully dissolved, the prepared reagent 
were made on day of use. 
 
2.3.5. Test procedure  
               The test was done as described by manufacture as follows: 
1/ Avian influenza coated plate were removed from sealed bag and 
location of samples on template were recorded.  
2/ 0.1 ml of negative control were added into AI  and BI wells.  
3/ 0.1 ml of positive control  were added into  CI   and DI wells.  
4/ 0.1 ml of diluted samples  were added  into appropriate wells, where 
any anti–AI antibodies present would bound and form an antigen-antibody 
complex. Then plate were covered with lid and incubated at room 
temperature (22-27) ° C for 30 minutes.  
5/ Contents of wells were aspirated and washed 4 times with wash buffer 
(0.3 ml per well), non specific antibodies and other serum proteins were 
washed away. Then plate were inverted and tapped firmly on absorbent 
paper.  
6/ 0.1 ml of Conjugate Reagent were added into appropriate wells. Then 
plates were covered with lid and incubated at room temperature (22-27) ° 
C for 30 minutes. 
7/ Contents of wells were aspirated and washed 4 times with wash buffer  
(0.3 ml per well). Then plate were inverted and tapped firmly on absorbent 
paper. 
8/ 0.1 ml of Substrate Reagent were added into appropriate wells. Then 
plate were covered with lid and incubated at room temperature (22-27) ° 
C for 15 minutes. 
9/ 0.1 ml of Stop Solution were added to appropriate wells to stop 
reaction, a yellow color  is developed if anti-AI antibodies is present  and 
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the intensity is directly related to the amount of anti-AI present in the 
sample.    
10/ The microtitre plate reader were blanked on air and recorded the 
absorbance of controls and samples by reading at 405 nm. 
 
 
2.3.6. Interpretation of results  
 
           Validity of  the test result was dependent on  the mean negative 
control absorbance  which  read  below 0.3 and the difference between 
the mean negative control and the mean positive control should be  
greater than 0.15.  
           Test sample values would  relative to the control values. The AI 
positive control was carefully standardized  to represent significant 
amounts of antibodies  to AI in chicken  serum.  The relative amounts of 
antibodies in chicken samples was calculated by reference to the positive 
control. This relationship was expressed as S/P ratio (Sample to Positive 
Ratio). Samples with an S/P of 0.5 or greater contained anti-AI antibodies 
and were considered positive.  
 
Calculation of S/P ratio: 
   
Mean of test sample -Mean of negative control 
Mean of positive control – Mean of negative control  
 
 
Calculation of Antibody  Titre:  
 
The following equation relates the S/P of samples at a 1:500 dilution to an 
end point titre.  
Log 10 Titre: 1.1 * log (SP) + 3.156  
Antilog = Titre  
Antibody Status  Titre RangeS/P value 
Negative 667 or less0.499 or less
Positive 668 or greater 0.500 or greater 
 
BioChek software programme was used with the AI kit to calculate S/P 
values and  titres. 
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2.4. Agar Gel Precipitation Test 
 
                    The test  was done according to(OIE manual, 2004). Antigen 
of avian influenza H5N1 was obtained from OIE/FAO  laboratory for AI 
and NDV, used in the AGPT.  
 
2.4.1. Preparation of agar gel : 
                    This was prepared by dissolving 1 gram of purified agar and 
8 gram of sodium chloride in 100 ml distilled water. The solution was 
heated in water bath for 4 minutes. The gel was distributed in 5 ml 
amounts in plates, placed on the bench at room temperature to solidify 
and kept at 4°C. 
 
2.4.2. Method of examination  of tested sera in agar plates: 
 
                   The prepared agar plates were used, a  rosette of six 
peripheral wells and central well were cut with a template, wells of 
approximately 5 mm in diameter, and 2–5 mm apart. The plugs were 
carefully removed with a Pasteur pipette. The distance between the 
central well and the peripheral well was 0.3 cm. Each peripheral wells 
were  filled with 0.025 ml of  tested sera using microtitre  pipette while the 
central wells were filled with 0.025 ml of antigen H5N1. A 0.025 ml of  
positive serum control was added to one peripheral well adjacent to tested 
sera, this   would made a line to identify between positive and negative 
tested sera.  The plates were incubated in a humid chamber at 37°C and 
examined daily in a dark room through transmitted light for precipitation 
line for 48 hours. 
 
2.5. Hemagglutination (HA) and Hemagglutination  
Inhibition (HI) tests 
 
2.5.1. Preparation of 1% RBCs suspension  
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                  2.5 ml  blood was collected  aseptically  from the wing vein of 
apparently  healthy chicken into equal volume of Alsever's  solution. The 
blood was placed into sterile tube, and then centrifuged at 1000 rpm for 
10 minutes. The supernatant was discarded and equal volume of sterile 
Phosphate Buffer Saline(PBS) was added to packed RBCs, mixed and 
centrifuged at 1000 rpm for 10 minutes. This washing process was 
repeated three times, then 1% suspension of RBCs was prepared in 
sterile Phosphate Buffer Saline(PBS)  and stored at 4°C until  used for 
detection the presence of agglutinating agents in HA and HI tests. 
 
2.5.2. Hemagglutination (HA) test  
                 This was applied as described in Beard (1989). Antigen of 
avian influenza H7N1 was obtained from OIE/FAO  laboratory for AI and 
NDV, for use in the HA test.   
The test was performed in plastic U- shaped microtitre plates. 0.025 ml of 
PBS was placed in all wells of row A  by  multichannel pipettor.  Amounts 
of 0.025 ml of antigen H7N1 was added to the first well in row A. Two-fold 
dilution was made.  0.025 ml of RBCs 1%  suspension was added to each 
well. The plate was shaken gently and incubated at room temperature for 
30 minutes. Row C was left as RBCs control. 
              
                 The HA titer was the reciprocal of the last dilution which 
completely agglutinate the RBCs.  
 
2.5.3. Hemagglutination   inhibition ( HI )  test  
2.5.3.1. Preparation of 4HA unit of the virus:  
                 Hemagglutination test was made on undiluted influenza antigen 
H7N1 which was obtained from OIE/FAO  laboratory for AI and NDv.  
According to Cunningham (1973) the last well that give complete  HA was 
considered 1 HA unit and the previous well considered the 2HA and  
accordingly, the  4HA unit were accurately calculated. The virus 
suspension was then diluted to contain 4HA unit per 0.025 ml.  
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2.5.3.2. Method of Hemagglutination  inhibition test :  
                     According to Allan et al. (1978), volumes of 0.025 ml PBS 
was added to each well of U-shaped microtitre plates. Volumes of 0.025 
ml of tested sera were added in the first well of rows except row H. Two-
fold serial dilutions of the tested sera were prepared across the plates. 
0.025 ml of 4HA unit of antigen H7N1 was added to each well except row 
H. The plates were shaken and left for 30 minutes at room temperature 
for antigen-antibody reaction to take place. After that, volumes of  0.025 
ml of 1% RBCs suspension was added to each well.  The test was read 
after 30 minutes incubation at room temperature. The HI titer was the  
reciprocal of the last dilution showing completely inhibits 
hemagglutination. Row H containing 0.025 ml of PBS and 0.025 ml of 
RBCs only to show   inhibition.  
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CHAPTER  THREE  
 
RESULTS 
 
 
 
 3.1. Collection of blood samples 
 
                    A total of 250 serum samples were collected from broiler and 
layer chicken from different farms in Khartoum North.  
     
 
3.2. Prevalence of antibodies against AI type A as detected 
by ELISA    
 
                    Two hundreds and fifty blood samples were tested by ELISA 
to investigate the presence of antibodies against avian influenza  virus  
type A. 
 
Table 3 shows the result of testing 250 sera for antibodies against AI type 
A  by ELISA. 20 sera (8 %) were positive and 230 sera (92 %) were 
negative.  
Figure 1 shows that 19 sera out of 160 sera (11.9 %) from layer chicken 
were positive and 141 sera (88.1 %)  were negative, and 1 serum out of 
90 sera ( 1.1 %) from broiler chicken was positive and 89 sera (98.9 %) 
were negative.  
Figure 2 shows ELISA, microtitre plate. 
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Table 4 shows that the  results of  testing chicken sera collected from 
layer  chicken in  Khartoum North according to poultry farms  using ELISA 
to detect  antibodies against avian influenza virus type A.    
Table 5 shows that the  results of  testing chicken sera collected from 
broiler  chicken  in  Khartoum North  according to poultry farms  using 
ELISA  to detect  antibodies against avian influenza virus type A.  
 
   
Table 3:  
Prevalence of antibodies against  AI type A  in chickens in Khartoum 
North as detected by ELISA 
 
ELISA - ve (%)ELISA + ve (%) Number of samples
230 (92 %)20 (8 %)250
 
Table 4: 
Prevalence of Abs against  AI type A  in  sera collected from layer 
chicken  in Khartoum North as  detected by  ELISA according to 
poultry farm 
 
ELISA –ve(%)ELISA +ve (%) Number of samplesLocation
7(100 %)
8(88.9 %)
31(96.9 %)
21(100 %)
13(86.7 %)
10 (77 %)
10(100 %)
10(55.6 %)
19(100 %)
12(75 %)
0(0 %)
1(11.1 %)
1(3.1 %)
0(0 %)
2(13.3 %)
3(23 %)
0(0 %)
8(44.4 %)
0(0 %)
4(25 %)
7
9
32
21
15
13
10
18
19
16
Shambat 1
Shambat 2 
Droshab1 
Droshab2
Elkabashi 1
Kadro1
Kadro2
Kadro 3
Elkabashi 2
Halfaia2
141(88.1%)19(11.9%)160Total
 
Table 5: 
Prevalence of Abs against  AI type A in sera collected from broiler 
chicken  in Khartoum North  as detected by ELISA according to 
poultry farm 
 
ELISA –ve (%)ELISA +ve (%) Number of 
samples
Location
 31
9(100 %)0(0 %)9Halfaia 1 
32(97 %)1(3 %)33Droshab 3
48(100 %)0(0 %)48East Nile
89(98.9%)1(1.1%)90Total
 
  
  
  
 
 
3.3. Agar Gel Precipitation test 
 
                  AGPT was applied to the sera collected from layer and broiler  
chicken  from Khartoum North  which were positive by ELISA to 
antibodies against avian influenza type A, using H5N1 antigen. The  
control serum gave slightly faint precipitation band, which was close to the 
antigen well, the tested sera gave no precipitation band against H5N1 
antigen after 48 hours of incubation (Figure 3).  
 
3.4. Hemagglutination  test 
                                            
                   H7N1  antigen gave titer 6log2    when tested by HA test. 4HA 
unit in well number 4,  the dilution of H7N1 antigen was 1:16 (Figure 4). 
 
3.5. Hemagglutination inhibition test 
                   HI test was applied to the sera collected from layer and broiler  
chicken  from Khartoum North which were positive by ELISA to antibodies 
against avian influenza type A, using H7N1 antigen (Figure 5). The results 
showed that no antibodies against H7N1 antigen were detected in the 
serum samples.  
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Figure (1): Prevalence of  antibodies against AI 
type A in sera collected from  layer and broiler 
chickens in Khartoum North as deteced by ELISA
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 1=  layer 
  2=  broiler 
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Figure (2): ELISA, microtitre plate. 
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  Figure (3): Agar gel precipitation test, control antigen 
  in the central well and collected sera in the peripheral 
  wells.  
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 Figure (4): Photograph showing Hemagglutination 
test. 
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  Figure (5): Photograph    showing   Hemagglutination 
  Inhibition test. 
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CHAPTAR  FOUR 
DISCUSSION  
  
                Avian influenza affects the respiratory, enteric or nervous 
systems of many species of birds. Viruses of relatively low virulence may 
cause few signs whereas others cause high mortality (Ardans and 
Maclachlan, 2004). Avian influenza has become one of the biggest threats 
for human and animal health.    
                This study was conducted to investigate  the presence of  
antibodies against avian influenza virus  type A in layer and  broiler  
chickens in Khartoum North. Commercial ELISA kits that detect antibody 
against the nucleocapsid protein as recommended by OIE, 2005 were 
used. The indirect ELISA is a reliable test amenable to semiautomation 
and the rapid survey of large numbers of samples (Swayne et al., 1998). 
               A total of 250 sera were collected from apparently healthy 
chickens ( 190 samples from layer chicken and 60 samples from broiler 
chicken ) in Khartoum North, in January/February 2008.  All sera were 
tested by ELISA to investigate the presence of antibodies against avian 
influenza  virus  type A. The results  showed that  8% were positive. 
Elamin (2000) reported that 28.4% of  sera tested  from chicken  were 
positive  when using ELISA to detect antibodies against avian influenza 
type A in Khartoum State. Ali et al. (2007) reported that 86.4 % of sera   
were positive when tested by indirect ELISA test to detect antibodies 
against avian influenza type A,  in  samples collected from unvaccinated  
chickens in different localities in Sudan during 2003 to early 2006. In the 
present  study the prevalence rate of antibodies against AI type A is  
lower than that obtained by Elamin (2000) and  Ali et al., (2007), this is 
probably due to difference of locations in which studies were  conducted. 
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The different attempts of avian control  could also play role in reducing 
disease spread.  
              In this study the prevalence rate of antibodies against avian 
influenza  virus  type A in layer chicken was  11.9 % and in  broiler 
chicken was  1.1 %. The prevalence rate of antibodies against avian 
influenza  virus  type A in layer chicken is higher than that  in broiler 
chicken. This is probably due to the fact that  layer chicken have long 
period of exposure  to the virus than broiler chicken.  
               AGPT have been widely and routinely used to detect specific 
antibodies against avian influenza in chicken and turkey flocks as an 
indication of infection. AGPT  was applied to the sera which were positive 
by ELISA to antibodies against avian influenza type A, using H5N1 
antigen.  The results showed that no antibodies against H5N1 antigen 
were detected in chicken sera which were positive by ELISA to antibodies 
against avian influenza type A. Saeed (2006)  detected antibodies against 
H5 antigen when  using HI test, and found that 2%  of chicken sera were 
positive to H5 antigen.   Kamaleldein (2007) reported that 1.8%  of tested 
sera from layer chickens in Khartoum and Bahry were  positive, when 
tested against H5 antigen using HI test. There is difference between result 
in the present study and the results  obtained by Saeed (2006) and 
Kamaleldein (2007); this is probably due to variation in type of test which 
used to detect antibodies against H5 antigen, in this study used AGPT 
and Saeed (2006) and Kamaleldein (2007) used HI test to detect 
antibodies against H5 antigen.  
              HI test is the subtype-specific test recommended. It is a sensitive 
and specific when epidemiology appropriate antigen is used (FAO, 
2004b). HI test was applied to the sera which were positive by ELISA  to 
antibodies against avian influenza type A, using H7N1 antigen.  The 
results showed that no antibodies against H7N1 antigen were detected in 
chicken sera which were positive by ELISA test to antibodies against 
avian influenza type A. Saeed (2006)  reported that 21% of  tested sera  
from chickens in Shambat area were positive when used HI test against 
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H7 antigen.  Kamaleldein (2007) reported that  32.1% of sera  from layer 
chickens in Khartoum and Bahry were positive, 5.9% of sera   from broiler 
chickens in Bahry and Omdurman were positive, when tested against 
H7N3 antigen using HI test. There is difference between result in this 
study and the results obtained by Saeed (2006) and Kamaleldein (2007); 
because   Saeed (2006) and Kamaleldein (2007) took their samples 
before the outbreak of Highly Pathogenic Avian Influenza(HPAI) in April 
2006. Ministry of Animal Resources and Fishers used depopulation, 
cleaning and disinfection to eradicate HPAI from the Sudan. The samples 
in the present study took after the outbreak of  HPAI  in April 2006.   
                  It was not possible to do a complete subtyping because only 
two antigen were available.    
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CONCLUSION     
 
 
               In  this study no antibodies against H5N1 and H7N1 antigens 
were detected in Khartoum North when used AGPT and HI test, 
respectively. 
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RECOMMENDATION 
 
              Routine  and regular survey  in individual birds or flocks for 
serologic evidence of Avian Influenza Virusinfections is important for early 
detection and to clarify the real situation of the disease. 
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APPENDICES   
  
  
 
1.  Phosphate Buffer Saline (PBS)    PH 7.4    
    
This was prepared as follow:  
 
Solution A 
  
NaCl                         8.00 gm  
KCl                               0.20 gm  
Na2HPO4                          1.15 gm  
KH2PO4                                 0.20 gm  
 Distilled water                         800 ml  
 
Solution B  
 
CaCl2                                         0.10 gm 
Distilled water                         100 ml 
 
Solution C 
  
MgCl2.6HO2                               0.10 gm  
Distilled water                               100 ml  
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Each solution was prepared in a separate container and autoclaved  at 
121°C for 15 minutes. After cooling, solution B and C  were  added to 
solution A and stored at 4°C.  
 
 
2. Alsever,s  solution (anticoagulant)  
  
This was contained of: 
 
D-glucose                                    20.5 gm  
NaCl                                             4.2 gm  
Na citrate                                      8.0 gm  
Citric acid                                     0.55 gm 
The mixture was completed to one liter with distilled water and autoclaved 
at 115 °C for 10 minutes.  
 
 
 
 
 
 
3. Preparation of agar gel:  
 
Purified agar                   1 gram  
 
NaCl                                8 gram 
 
 
Distilled Water               100 ml 
 
 
4. Results of ELISA test: 
 
 
 
 
  
  
                            
 
 
 
 
 
 
 56
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
   
 
